K193649

Substantially Equivalent

Yumizen C1200 Creatinine PAP

Applicant: HORIBA ABX SAS
Product code: JFY
Advisory panel: Clinical Chemistry
Date received: 2019-12-30
Decision date: 2021-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier Cedex 4, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.